Gram-negative bacillary meningitis in adult post-neurosurgical patients

Surgical Neurology

Volumn 52, Issue 5, 1999, Pages 438-444

  Lu, Cheng Hsien ^a   Chang, Wen Neng ^a   Chuang, Yao Chung ^a   Chang, Hsueh Wen ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Gram negative bacillary meningitis; Postneurosurgery; Prognostic factors

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CITROBACTER FREUNDII; CLINICAL ARTICLE; CLINICAL EXAMINATION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA; MALE; NEUROSURGERY; POSTOPERATIVE INFECTION; PROGNOSIS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM; CEPHALOSPORIN RESISTANCE; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032776960     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(99)00129-9     Document Type: Article

References (27)

1. Baltas I., Tsoulfa S., Sakellariou P., Vogas V., Fylaktakis M., Kondodimou A. Posttraumatic meningitis bacteriology, hydrocephalus, and outcome . Neurosurgery. 35:1994;422-427.
2. Bergogne-Bérézin E., Joly-Guillou M.L. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus. J Antimicrob Chemother. 18:(suppl E):1986;35-39.
3. Berk S.L., McCabe W.R. Meningitis caused by Acinetobacter calcoaceticus var anitratus, a specific hazard in neurosurgical patients. Arch Neurol. 38:1981;95-98.
4. Berk S.L., McCabe W.R. Meningitis caused by Gram-negative bacilli. Ann Intern Med. 93:1980;253-260.
5. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 2:1987;302-306.
6. Buckwold F.J., Hand R., Hansebout R.R. Hospital-acquired bacterial meningitis in neurosurgical patients. J Neurosurg. 46:1977;494-500.
7. Cherubin CE, Corrado ML, Nair SR, Gombert ME, Landesman S, Humbert G. Treatment of Gram-negative bacillary meningitis: role of the new cephalosporin antibiotics. Rev Infect Dis 1982;4:S453-64.
8. Cherubin C.E., Marr J.S., Sierra M.F., Becker S. Listeria, and Gram-negative bacillary meningitis in New York City, 1972-1979. Am J Med. 71:1981;199-209.
9. Finland M., Barnes M.W. Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. J Infect Dis. 136:1977;400-415.
10. Gerding D.N., Buxton A.E., Hughes R.A., Cleary P.P., Arbaczawski J., Stamm W.E. Nosocomial multiply resistant Klebsiella pneumoniae epidemiology of an outbreak of apparent index case origin . Antimicrob Agents Chemother. 15:1979;608-615.
11. Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med. 1996;335:1445-2.
12. Gorse G.J., Thrupp L.D., Nudleman K.L., Wyle F.A., Hawkins B., Cesario T.C. Bacterial meningitis in the elderly. Arch Intern Med. 144:1984;1603-1607.
13. Jacoby G.A., Archer G.L. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med. 324:1991;601-612.
14. Jacoby G.A., Carreraa I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended spectrum β-lactamase. Antimicrob Agents Chemother. 34:1990;858-862.
15. Landesman S.H., Corrado M.L., Shah P.M., Armengaud M., Barza M., Cherubin C.E. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Am J Med. 71:1981;693-703.
16. LeFrock J.L., Molavi A., Simth B., Black P., Rosenberg M., Rolston K., Brodner R., Chandrasekar P., Henao L., Kannagara D.W. Effectiveness of cefotaxime in Gram-negative meningitis. Neurosurgery. 15:1984;679-682.
17. Mancebo J., Domingo P., Blanch L., Coll P., Net A., Nolla J. Post-neurosurgical and spontaneous Gram-negative bacillary meningitis in adults. Scand J Infect. 18:1986;533-538.
18. Mangi R.J., Quintiliani R., Andriole V.T. Gram-negative bacillary meningitis. Am J Med. 59:1975;829-836.
19. Mombelli G., Klastersky J., Coppens L., Daneau D., Nubourgh Y. Gram-negative bacillary meningitis in neurosurgical patients. J Neurosurg. 59:1983;634-641.
20. Olson D.A., Hoeprich P.D., Nolan S.M., Goldstein E. Successful treatment of Gram-negative bacillary meningitis with moxalactam. Ann Intern Med. 95:1981;302-305.
21. Preston S.L., Briceland L.L. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli. Ann Pharmacother. 27:1993;870-873.
22. Quagliarello V.J., Scheld W.M. Treatment of bacterial meningitis. N Engl J Med. 336:1997;708-716.
23. Rouveix E., Bure A.M., Regnier B. Experience with imipenem/cilastatin in the intensive care unit. J Antimicrob Chemother. 18:(suppl E):1986;153-160.
24. Sanders W.E. Jr, Sanders C.C. Inducible β-lactamase clinical and epidemiologic implications for use of newer cephalosporins . Rev Infect Dis. 10:1988;830-838.
25. Schonwald S, Beus I, Lisic M, Car V, Gmajnicki B. Brief report: ciprofloxacin in treatment of Gram-negative bacillary meningitis. Am J Med 1989;87:5A-248S-9S.
26. Sirot D.L., Goldstein F.W., Soussy C.J., Courtieu A.L., Husson M.O., Lemozy J. Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae a 3-year survey in France . Antimicrob Agents Chemother. 36:1992;1677-1681.
27. Smith C.E., Tillman B.S., Howell A.W., Longfield R.D., Jorgensen J.H. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum β-lactamase. Antimicrob Agents Chemother. 34:1990;1290-1293.